Apogem Capital closes its seventh secondary fund at $1.43 billion in New York City as global investors boost private markets growth momentum

Apogem Capital, a private markets investment firm headquartered in New York City, has successfully closed its seventh secondaries fund, Apogem Secondary Fund VII (ASF VII), raising an impressive $1.43 billion.

This milestone reflects strong confidence from both long-term partners and a new roster of global investors.

Broad Support from Global Investors

The fund attracted backing from a wide variety of institutional investors, including public and private pension plans, family offices, and registered investment advisors (RIAs).

Notably, Apogem’s own employees and its parent company, New York Life Insurance Company, contributed significant commitments, highlighting the internal confidence in the fund’s strategy and potential.

Focused on North American Middle Market

ASF VII will continue Apogem’s established approach of investing in a diversified portfolio of GP-led and LP secondary transactions across the North American middle market.

Apogem has earned a strong reputation as a sole buyer in LP secondaries, as well as a lead or co-lead investor in GP-led deals, offering investors access to a wide range of private market opportunities.

Leadership and Expertise

Under the leadership of CEO Josh Niedner, Apogem Capital manages roughly $44 billion in assets as of December 31, 2025.

Suggested Readings (News continues below)

Investigators uncover disturbing pattern as scientists vanish and die under unclear circumstances across major U.S. research facilities in Los Angeles and New Mexico

Prince Charles nephew Peter Phillips reveals wedding plans and ties knot with Harriet Sperling in a private ceremony at Gloucestershire venue in summer 2026

Emma Raducanu battles illness and pulls out of Linz Open in Austria as British star fights to regain full fitness and form

Manchester Crown Court Jails Matloob Hussain as Disqualified Director Misuses Covid Loans and Violates Business Laws in Greater Manchester

The firm offers a comprehensive suite of private market solutions, including direct lending, private equity funds and co-investments, GP-led transactions and LP secondaries, GP stakes, and private real assets.

With over 250 professionals on its team—including more than 120 dedicated investment experts—Apogem combines specialized market expertise with the stability and long-term perspective provided by its parent, New York Life Insurance Company.

Apogem operates as a wholly owned subsidiary of New York Life through New York Life Investment Management Holdings, LLC.

Impact and Consequences

The successful closure of ASF VII positions Apogem to further solidify its leadership in middle-market secondaries and GP-led transactions.

Investors gain access to a robust, diversified portfolio, while Apogem strengthens its capacity to pursue larger, more complex deals.

This fund also underscores the growing appeal of private market investments among institutional and family office investors seeking stable, long-term returns.

What’s Next?

Apogem Capital is expected to deploy ASF VII’s capital strategically across both GP-led and LP secondary transactions throughout North America.

The firm will leverage its deep experience and network to identify attractive opportunities, while maintaining a focus on risk management and portfolio diversification.

Investors can anticipate a mix of co-investment and lead opportunities designed to generate consistent returns over the fund’s lifecycle.

Summary

Apogem Capital has closed its $1.43 billion ASF VII fund, backed by global institutional investors, employees, and its parent company.

The fund continues the firm’s focus on middle-market GP-led and LP secondary transactions, building on a successful track record and strong industry reputation.

Bulleted Takeaways

• Apogem Capital raises $1.43 billion for ASF VII, its seventh secondaries fund.
• Fund supported by global institutional investors, employees, and New York Life Insurance Company.
• Focused on North American middle-market GP-led and LP secondary transactions.
• CEO Josh Niedner leads Apogem, which manages $44 billion in assets.
• Team of 250+ professionals provides deep domain expertise and long-term investment perspective.
• ASF VII enhances Apogem’s capacity to pursue complex deals and deliver diversified returns to investors.